Latest Insider Transactions at Compass Pathways PLC (CMPS)
This section provides a real-time view of insider transactions for Compass Pathways PLC (CMPS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of COMPASS Pathways plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of COMPASS Pathways plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,855
-0.07%
|
$19,985
$7.82 P/Share
|
|
Nov 01
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,470
-0.03%
|
$7,350
$5.78 P/Share
|
|
Nov 01
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-0.04%
|
$7,630
$5.78 P/Share
|
|
Nov 01
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,526
-0.04%
|
$7,630
$5.78 P/Share
|
|
Nov 01
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
1,470
-0.03%
|
$7,350
$5.78 P/Share
|
|
Nov 01
2023
|
Annalisa Jenkins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
143
-0.71%
|
$715
$5.78 P/Share
|
|
Aug 01
2023
|
Kabir Nath Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,000
-6.65%
|
$40,000
$8.95 P/Share
|
|
Aug 01
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,470
-0.03%
|
$11,760
$8.95 P/Share
|
|
Aug 01
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-0.04%
|
$12,208
$8.95 P/Share
|
|
Aug 01
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,526
-0.04%
|
$12,208
$8.95 P/Share
|
|
Aug 01
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
1,470
-0.03%
|
$11,760
$8.95 P/Share
|
|
Aug 01
2023
|
Annalisa Jenkins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.79%
|
$1,288
$8.95 P/Share
|
|
May 02
2023
|
Annalisa Jenkins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
25
-0.12%
|
$175
$7.97 P/Share
|
|
May 02
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,526
-0.04%
|
$10,682
$7.97 P/Share
|
|
May 02
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
1,470
-0.03%
|
$10,290
$7.97 P/Share
|
|
May 02
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,470
-0.03%
|
$10,290
$7.97 P/Share
|
|
May 02
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-0.04%
|
$10,682
$7.97 P/Share
|
|
Feb 02
2023
|
Matthew A Owens General Counsel & CLO |
BUY
Grant, award, or other acquisition
|
Direct |
10,800
+33.43%
|
-
|
|
Feb 02
2023
|
Michael Falvey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+50.0%
|
-
|
|
Feb 02
2023
|
Ekaterina Malievskaia > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
11,700
+0.27%
|
-
|
|
Feb 02
2023
|
Kabir Nath Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,200
+25.1%
|
-
|
|
Feb 02
2023
|
George Jay Goldsmith > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
11,700
+0.27%
|
-
|
|
Feb 01
2023
|
Matthew A Owens General Counsel & CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,693
-13.65%
|
$16,930
$10.61 P/Share
|
|
Feb 01
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
5,283
-0.12%
|
$52,830
$10.61 P/Share
|
|
Feb 01
2023
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
3,301
-0.08%
|
$33,010
$10.61 P/Share
|
|
Feb 01
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,301
-0.08%
|
$33,010
$10.61 P/Share
|
|
Feb 01
2023
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
5,283
-0.12%
|
$52,830
$10.61 P/Share
|
|
Dec 20
2022
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,409
-0.1%
|
$39,681
$9.2 P/Share
|
|
Dec 20
2022
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
4,577
-0.11%
|
$41,193
$9.2 P/Share
|
|
Dec 20
2022
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,577
-0.11%
|
$41,193
$9.2 P/Share
|
|
Dec 20
2022
|
George Jay Goldsmith > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
4,409
-0.1%
|
$39,681
$9.2 P/Share
|
|
Aug 01
2022
|
Kabir Nath Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Mar 29
2022
|
Annalisa Jenkins Director |
SELL
Open market or private sale
|
Direct |
3,384
-14.25%
|
$40,608
$12.48 P/Share
|
|
Mar 29
2022
|
David Y Norton Director |
SELL
Open market or private sale
|
Direct |
3,384
-14.25%
|
$40,608
$12.48 P/Share
|
|
Mar 29
2022
|
George Jay Goldsmith > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,372
-0.15%
|
$76,464
$12.48 P/Share
|
|
Mar 29
2022
|
George Jay Goldsmith > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,372
-0.15%
|
$76,464
$12.48 P/Share
|
|
Mar 29
2022
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,372
-0.15%
|
$76,464
$12.48 P/Share
|
|
Mar 29
2022
|
Ekaterina Malievskaia > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,372
-0.15%
|
$76,464
$12.48 P/Share
|
|
Feb 01
2022
|
Guy Goodwin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+50.0%
|
-
|
|
Feb 01
2022
|
George Jay Goldsmith > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
13,000
+0.3%
|
-
|
|
Feb 01
2022
|
George Jay Goldsmith > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
29,000
+0.67%
|
-
|
|
Feb 01
2022
|
Ekaterina Malievskaia > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
29,000
+0.67%
|
-
|
|
Feb 01
2022
|
Ekaterina Malievskaia > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
13,000
+0.3%
|
-
|
|
Feb 01
2022
|
Matthew A Owens General Counsel & CLO |
BUY
Grant, award, or other acquisition
|
Direct |
12,400
+50.0%
|
-
|